Caricamento...
Non‐responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions
AIMS: To determine the characteristics of “non‐responders” to intravitreal bevacizumab treatment in choroidal neovascularisation (CNV). METHODS: Forty‐three patients with visual loss due to neovascular age‐related macular disease (ARMD) (44 eyes) underwent intravitreal injections of 1.25 mg (0.05 ml...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Group
2007
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2000982/ https://ncbi.nlm.nih.gov/pubmed/17537784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.113902 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|